Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Chengdu Easton Biopharmaceuticals Co Change In Payables And Accrued Expense?

Chengdu Easton Biopharmaceuticals Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Chengdu Easton Biopharmaceuticals Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

Chengdu Easton Biopharmaceuticals Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ¥0 Mil. It means Chengdu Easton Biopharmaceuticals Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Chengdu Easton Biopharmaceuticals Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Chengdu Easton Biopharmaceuticals Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Easton Biopharmaceuticals Co Change In Payables And Accrued Expense Chart

Chengdu Easton Biopharmaceuticals Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Chengdu Easton Biopharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Chengdu Easton Biopharmaceuticals Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Chengdu Easton Biopharmaceuticals Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Chengdu Easton Biopharmaceuticals Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Easton Biopharmaceuticals Co Ltd (SHSE:688513) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731

Website

http://www.eastonpharma.cn

Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Headlines

No Headlines